abcnews.go.com
Open in
urlscan Pro
18.66.122.70
Public Scan
Submitted URL: https://grey8news.com/link?dest=eVpRSjMrVStxTFJSVzV5WHdsdEZnOTZiS29DcEphUjMwSGZLK3hyVmE5cWdEc1R2a08yWUpvRkdmc2Q3ZUhWSj...
Effective URL: https://abcnews.go.com/Health/wireStory/france-start-pfizers-covid-19-drug-eu-82624872
Submission: On February 05 via manual from US — Scanned from DE
Effective URL: https://abcnews.go.com/Health/wireStory/france-start-pfizers-covid-19-drug-eu-82624872
Submission: On February 05 via manual from US — Scanned from DE
Form analysis 1 forms found in the DOM
<form><span class="search"><span class="search__trigger search__trigger--default"></span><span class="search--default"><input type="text" class="search__input" placeholder="Search Headlines, News and Video..."><input type="submit"
class="search__input__submit"><span class="search__input__icon"></span></span></span></form>Text Content
ABC NEWS VIDEO LIVE SHOWS CORONAVIRUS JAN. 6 RIOT OLYMPICS Interest Successfully Added We'll notify you here with news about Turn on desktop notifications for breaking stories about interest? OffOn FRANCE TO START USING PFIZER'S COVID-19 DRUG, FIRST IN EU France says it will start administering Pfizer’s coronavirus antiviral drug this week, the first pill for treating COVID-19 approved in the 27-nation EU ByThe Associated Press 2 February 2022, 16:39 • 2 min read Share to FacebookShare to TwitterEmail this article The Associated Press People wearing masks stroll in Saint-Jean-de-Luz southwestern France, Wednesday, Fev...Read MoreRead More PARIS -- France says it will start administering Pfizer’s coronavirus antiviral drug this week, the first pill for treating COVID-19 approved in the 27-nation EU. The country is still reporting among the world's highest per-capita daily infections, but virus-related critical care hospitalizations are easing, and the French government on Wednesday started lifting restrictions related to the surge in omicron cases. Masks are now no longer required outdoors in France, large crowds are again allowed in concerts and sports venues and a government order to work from home part-time has been lifted. Meanwhile, France has received its first 10,000 doses of the Pfizer drug Paxlovid and they will be available in pharmacies starting Friday, the Health Ministry said Wednesday. It says it's the first European Union country to start providing the treatment since it won regulatory approval last week. It will be given to adults with symptoms who don’t require oxygen and who are at higher risk of severe disease, according to European Medicines Agency guidelines. Supplies of the drug remain limited worldwide. The EMA last week recommended that Paxlovid be authorized for use, saying it could help people infected with COVID-19 avoid more serious disease and being hospitalized. The drug was cleared by regulators in the U.S. and Britain in December. An antiviral pill from Merck also is expected to soon be authorized. Both drugs are expected to be effective against omicron because they do not target the spike protein where most of the variant’s worrisome mutations reside. ——— Follow all AP stories on the pandemic at https://apnews.com/hub/coronavirus-pandemic. Comments (0) Share to FacebookShare to TwitterEmail this article -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- TOP STORIES 'WE'LL LOSE OUR COUNTRY': PENCE HITS BACK AT TRUMP'S JAN. 6 CLAIMS Feb 04, 8:41 PM NYC MAYOR ERIC ADAMS APOLOGIZES FOR USING RACIAL SLUR 3 hours ago 2022 WINTER OLYMPICS OPENING CEREMONY: BEST MOMENTS FROM THE EVENT 1 hour ago DISGRACED LAWYER MICHAEL AVENATTI FOUND GUILTY Feb 04, 8:43 PM SINGLE SUICIDE BOMBER KILLED US TROOPS, AFGHANS IN KABUL AIRPORT ATTACK: PENTAGON 2 hours ago ABC NEWS LIVE 24/7 coverage of breaking news and live events ABC NEWS NETWORK PRIVACY POLICY YOUR CA PRIVACY RIGHTS CHILDREN'S ONLINE PRIVACY POLICY INTEREST-BASED ADS ABOUT NIELSEN MEASUREMENT TERMS OF USE DO NOT SELL MY INFO CONTACT US Copyright © 2022 ABC News Internet Ventures. All rights reserved.